Tech that converts liquid cannabis to a gel could change the way Canadians consume cannabis

1w
3m read
Summary

The Sol-Gel technology is thanks to the work of a team of researchers, led by Dr. It is the last option that seems of the greatest immediate interest when it comes to the Sol-Gel technology. Australia’s University of Queensland (U.Q.) and Canada’s PreveCeutical Medical Inc. have teamed up for what is being called a revolutionary change in how patients will take medical cannabis: a liquid that converts to a gel. Their results indicated that CBD could be successfully delivered through the intranasal and transdermal routes. The deal includes a licence to the patent application, the university reports.

Article Preview

Australia’s University of Queensland (U.Q.) and Canada’s PreveCeutical Medical Inc. have teamed up for what is being called a revolutionary change in how patients will take medical cannabis: a liquid that converts to a gel.

The Sol-Gel technology is thanks to the work of a team of researchers, led by Dr. Harendra Parekh, at the U.Q.’s School of Pharmacy, which explains the liquid solution converts to a gel upon contacting “internal membranes of the human body, such as the nose.”

Vancouver-headquartered PreveCeutical — which, along with its partners, researches and develops solutions that...

Read the full article @ The Growth Op